medigraphic.com
ISSN 0016-3813 (Print)

2002, Number 6

<< Back Next >>

Gac Med Mex 2002; 138 (6)

The neurologic diseases.
I. Their dimensions and social repercussions.
II. Depression and dementia.
III. Trauma and tumors.
IV. Central nervous system infections.

Corona-Vázquez T, Campillo-Serrano C, López M, Mateos-G JH, Soto-Hernández JL

Language: Spanish
References: 56
Page: 533-546
PDF size: 75.10 Kb.


ABSTRACT

Neurologic diseases have important social and economic repercussions. The economic cost related to medications, caretakers, and therapists is evident, as well as the impact the disease may cause on the family. Epilepsy is the most frequent cause of medical care at the out-patient service of the Manuel Velasco Suárez National Institute of Neurology and Neurosurgery (NINN), in Mexico City and the estimated annual prevalence of this disease is 5.9 per 1,000 inhabitants. Parkinson’s disease, the most representative of movement disorders, affects 20% of the populating aged ›65 years. Depression and dementia are complex and heterogeneous neuropsychiatry disorders, representing the fifth cause of morbility after accidents, cardiovascular disease, liver cirrhosis and diabetes mellitus. During the last decades, encephalic trauma has been the first cause of mortality; among brain tumors, glioblastomas have the greatest impact. Among infectious disease of the central nerwors system (CNS), which are relatively infrequent as compared to gastrointestinal or respiratory infections; viral encephalitis, AIDS-associated toxoplasmosis, and tuberculous meningitis are the most frequent discharge diagnoses at the NINN. The need for a national registration system of neurologic diseases is unquestionable. Such a system would provide accurate data regarding the magnitude of problems related with such disease and help design adequate care and prevention programs.


REFERENCES

  1. Taylor A. Epilepsy and related syndromes in the fundamentals of clinical Neuropsychiatry. Oxford UK:University Press; 1999. p. 298-332.

  2. Dichter AM. Epilepsy. In: Angel PS, editors. Current treatment options in neurology, 1999;(Suppl 1):323-337.

  3. Rubio DF, García PF, Velasco FR. Prevalence of epilepsy in elementary school in Mexico. Epilepsia 1999;32(supl 1):111.

  4. Cascino DG, Britton WJ, Buchhalter S, Shin Ch, So LE. Continuum Epilepsy 2000;6:8-16.

  5. Bialik PR. Aspectos sociales de la epilepsia. En: Feria VA, Martínez D, Rubio DF, editores. Epilepsia: aspectos neurobio-lógicos, médicos y sociales. INNN: UNAM; 1997. p. 391-400.

  6. Tylor A. Dementia. In: The fundamentals of clinical neuropsychiatry. Oxford, UK: University Press; 1999. p. 362-365.

  7. Otero E. Parkinson. Incidencia y prevalencia. En: Otero E. Parkinson, enfoque al futuro. INNN: FCE; 1996. p. 19-24.

  8. Lambert D, Waters HCh. Essential tremor. In: Ringel PS editors. Current treatment optimation. Neurology 1999;1:6-13.

  9. 1. Organización Mundial de la Salud. CIE10 Trastornos mentales y del comportamiento. Madrid, España: Meditor; 1992.

  10. 2. American Psychiatry Association. DSM IV manual diagnóstico y estadístico de los trastornos mentales. Barcelona, España: Masson S.A.; 1995.

  11. 3. Boyd E. WNM. Psycho-social predictors of chronicity in depressed patients. British Journal of Psychiatry 2001;150: 648-654.

  12. 4. Blacker C, Clare A. Depressive disorders in primary care. Br J Psychiatry 1987;150:737-751.

  13. 5. Sireling LI, Paykel E, et al. Depression in general practice. Br J Psychiatry 1985;147:113-119.

  14. 6. Paykel ES, Priest RG. Recognition and management of depression in general practice: consensus statement. BMJ 1992;305:1198-202.

  15. 7. Wells KB, Hays RDea. Detection of depressive disorder for patients receiving prepaid or fee-for-service care. J Amer Med Inform Assn 1989;282.

  16. 8. Stoudemire A, Frank R, et al. The economic burden of depression. Gen Hosp Psychiatry 1986;8:387-394.

  17. 9. Lee AS, Murray RM. The long-term outcome of Maudsley depressives. Br J Psychiatry 1988;153:741-751.

  18. Goldberg D. The recognition of psychological illness by general practitioners. In: Ed GE, editors. Psychiatry in general practice. UK: University of Southampton; 1981.

  19. Pérez-Stable EJ, Miranda-Muñoz RF, et al. Depression in medical outpatients. Underrecognition and misdiagnosis. Arch Inter Med 1990;150:1083-1088

  20. Medina-Mora ME, et al. El uso de los servicios de salud por los pacientes con trastornos mentales: resultados de una encuesta en una población de escasos recursos. Salud Mental 1997;20:32-38.

  21. Rihmer Z, Barsi J, et al. Suicide rates in Hungary correlates negatively with reported rates of depression. J Affect Disord 1990;20:87-91.

  22. Henderson AS. Epidemiology of dementia disorders. In: Walker E, editors. Advance in neurology. New York: 1990. p. 15-25.

  23. Encuesta nacional sobre la sociodemografía del envejecimiento en México. Resultados sobre sociodemografía del envejecimiento en México. 1994.

  24. Small SA, Mayeux R. Delirium and dementia. In: Lewis PR, editors. Merrit’s neurology. Philadelphia, PA, USA: Lippincott Williams & Wilkins, 2000.

  25. Suh GH, Shah A. A review of the epidemiological transition in dementia-cross- national comparison of the indices related to Alzheimer’s disease and vascular dementia. Acta Psychiatr Scand 2001;104(1):4-11.

  26. Barinagarrementería-Aldatz F. Científicos y técnicos No 1. Manual de normas técnicas y lineamientos para la prevención y control de las enfermedades neurológicas en el primer nivel de atención. México, D.F. Instituto Nacional de Neurología; 1991.

  27. Hoy-Gutierrez MJ, González-Figueroa E, Kuri-Morales P. Epidemiología de la enfermedad cerebrovascular. Gac Med Mex 1996;132:223-230.

  28. García CA, Reding MJ, Blass JP. Overdiagnosis of dementia. J Am Geriatr. Soc 1981;29:407-410.

  29. Callahan CM, Hendrie HC, Tierney WM. Documentation and evaluation of cognitive impairment in elderly primary care patients. Ann Intern Med 1995;122:422-429.

  30. German PS, Shapiro S, Skinner EA. Detection and management of mental health problems of older patient by primary care providers. JAMA 1987;257:489-493.

  31. Breitner JCS, Welsh KA. Diagnosis and management of memory loss and cognitive disoders among elderly persons. Psychiatr Serv 1995;46:29-35.

  32. Erns RL, Hay JW. The US economic and social costs of Alzheimer disease revisited. Am J Public Health 1994;84: 1261-1264.

  33. Murray JL, López AD. The global burden of disease. A comprensive assessment of mortality and disability from disease, injuries, and risk factors in 1990 and projected to 2020. Boston, MA, USA: Harvard University Press; 1996.

  34. Fundación Mexicana para la Salud. El peso de la enfermedad en México: un doble reto. Economía y Salud. Documentos para el análisis y la convergencia. México: Fundación Mexicana para la Salud; 1994. p. 23-33.

  35. Frenk J. Mensaje del Dr. Julio Frenk Mora, Secretario de Salud, en ceremonia conmemorativa del Día Mundial de la Salud 2001. México: SSA; 2001. Ref type: electronic citation.

  36. Commission on Professional and Hospital Activities: The International classification of diseases, ninth revision. Clinical modifications (ICD 9 CM). Ann Arbor Commission of professional and Hospital Activities; 1986.

  37. Graves E. Detailed diagnosis and procedures. National hospital discharge survey, 1990. Vital Healt Stat 1992;13:18.

  38. Tator CH. Biology of neurological recovery and functional restoration after spinal cord injury. Neurosurgery. 1998;42(4): 696-708 .

  39. Aldrich EF, Eisenberg HM, Saydairjic et al. Diffuse brain swelling in severely brain injured children: A report from the NIH Traumatic Coma Bank. J Neurosurg 1992;76:450-454.

  40. Armstead WM. Kunth CD. Different cerebral hemodynamic responses following fluid percussion brain injury in the newborn and juvenile pig. J. Neurotrauma 1994;11: 487-497.

  41. Koraus JF, Black H, et al. The incidence of acute brain injury and serious impairment in a definite population. Epidemiology 1984;119:186-201.

  42. Marshal LF. Epidemiology and cost of central nervous system injury. Clin Neurosurg 1998. p. 105-112.

  43. Mclanley BP, Michaleck AN, Fenstenmaken RA, Plankett RJ, The impact of age and sex on the incidence of glial tumors in New York State from 1976 to 1995. J Neurosurg 2001;93:932-939.

  44. Kyonstas AP, Saya H. Epidemiology cytogenesis and molecular biology of brain tumors. Curr Opin Oncol 1993;5:474-480.

  45. Martínez R. Marcos ML, Figueroa S, et al. Estrogen and progesterone receptors in intracraneal tumors. Clin Neuropharmacol 1984;7:338-342,

  46. Plunkett RJ, Lis A, Barone TA, et al. Hormonal effects on glioblastoma multiforme in the nude rat model. J Neurosurg 1999;90:0721077.

  47. Pedersen PH, Edvarsen K, García Cabrera, et al. Migratory patterns in lac-2 transfected human glioma cells in rat brain. Inst J Can 1995;62:767-771.

  48. Paulus W, Tonn JB. Basement membrane invasion of glioma cells mediated by integrin receptors. J Neurosurg 1994;80:515-519.

  49. Murray CJL, López AD. Mortality by cause for eight regions of the world. Global burden of disease study. Lancet 1997;349:1269-1276.

  50. Murray CJL, Lopez AD. Alternative projections of mortality and disability by cause 1990-2020: global burden of disease study. Lancet 1997;349:1498-1504.

  51. 3 . Dirección General de Estadística e Informática de la Secretaría de Salud, México. Información básica sobre recursos y servicios del Sistema Nacional de Salud, 1994-2000. Salud Pública Mex 2000;42:S39-S49.

  52. Sistema Nacional de Vigilancia Epidemiológica. Epidemiología 2001;18(4):4-33.

  53. Sistema Nacional de Vigilancia Epidemiológica. Epidemiología 2001;18(3):4-19.

  54. Isunza Torres AM. Aspectos clínicos, electroencefalográficos y de imagen de pacientes con encefalitis viral en el INNyN. Análisis de 70 casos. Tesis de posgrado para obtener el título de Especialista en Neurología. México: INNyN-UNAM. 2000.

  55. Góngora-Rivera F, Santos-Zambrano J, Moreno-Andrade T, Calzada-López P, Soto-Hernández JL. The clinical spectrum of neurological manifestations of AIDS patients in Mexico. Arch Med Res 2000;31:393-398.

  56. Rojas-Echeveni LA, Soto-Hemández JL, Garza S, Martínez-Zubieta R, Miranda LI, García Ramos G, Zenteno M. Predictive value of digital substraction angiography in patients with tuberculous meningitis. Neuroradiology 1996;38:20-24.




2020     |     www.medigraphic.com